Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPredator Oil Regulatory News (PRD)

Share Price Information for Predator Oil (PRD)

Share Price is delayed by 15 minutes
Get Live Data
3.425    -0.025 (-0.72%)
Bid:
3.35
Ask:
3.50
Spread: 0.15 (4.478%)
Market Cap: £30.84m
PRD Live PriceLast checked at - London Stock Exchange

Intraday Predator Oil Share Chart

Dividend Declaration

4 Nov 2008 07:00

RNS Number : 3487H
Prodesse Investment Limited
04 November 2008
 



Prodesse Investment Limited

4 November 2008

Interim Dividend for the Third Quarter 2008

Prodesse Investment Limited has declared an interim dividend for the quarter ended 30 September 2008 of US$0.23 per share payable on 28 November 2008 to holders on the register on 14 November 2008. 

Dividends are calculated and paid in US dollars. Shareholders wishing for the conversion of dividend payments into Sterling should contact Computershare Investor Services (Channel Islands) Limited, Tel: 01534 825294. 

The exchange rate for payment to those who have elected to receive their dividends in Sterling will be set on 19 November 2008.

Details of the Company's Quarterly performance have been published in a separate announcement.

Enquiries

Sara Radford / Jean McMillan

BNP Paribas Fund Services (Guernsey) Limited

Tel: 01481 750850

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DIVEANFDEEAPFFE
Date   Source Headline
23rd Aug 20227:00 amRNSAdmission of Placing Shares
22nd Aug 20227:00 amRNSNotification of Investor Webinar
18th Aug 202211:00 amRNSNotice of Annual General Meeting
17th Aug 20224:25 pmRNSChange of Financial Advisors
17th Aug 202211:05 amRNSSecond Price Monitoring Extn
17th Aug 202211:00 amRNSPrice Monitoring Extension
17th Aug 20227:00 amRNSPlacing to Raise £3.3 Million
21st Jul 202211:24 amRNSNotification of Major Holdings
21st Jul 202211:24 amRNSDirector/PDMR Shareholding
19th Jul 20227:00 amRNSDrilling and Operations Update
15th Jul 20227:00 amRNSAdmission of Shares
12th Jul 20227:00 amRNSExercise of Warrants
29th Jun 20227:00 amRNSFinancial Statements Year ended 31 December 2021
7th Jun 20227:00 amRNSTrinidad Update - FRAM Loan
1st Jun 20222:05 pmRNSSecond Price Monitoring Extn
1st Jun 20222:00 pmRNSPrice Monitoring Extension
25th May 20227:00 amRNSLaunch of Mag Mell White Paper
12th May 20227:00 amRNSOperations Update and Directorate Changes
4th May 20224:41 pmRNSSecond Price Monitoring Extn
4th May 20224:35 pmRNSPrice Monitoring Extension
4th May 20222:06 pmRNSSecond Price Monitoring Extn
4th May 20222:01 pmRNSPrice Monitoring Extension
4th May 202211:06 amRNSSecond Price Monitoring Extn
4th May 202211:00 amRNSPrice Monitoring Extension
4th Apr 20222:05 pmRNSSecond Price Monitoring Extn
4th Apr 20222:00 pmRNSPrice Monitoring Extension
1st Apr 202210:05 amRNSIreland National Energy Summit
1st Apr 20227:00 amRNSChange of Registered Office Address
1st Apr 20227:00 amRNSAdmission of Placing Shares
31st Mar 20228:27 amRNSPlacing Update
25th Mar 20227:00 amRNSAdmission of Placing of Shares
24th Mar 202211:06 amRNSSecond Price Monitoring Extn
24th Mar 202211:00 amRNSPrice Monitoring Extension
17th Mar 20229:05 amRNSSecond Price Monitoring Extn
17th Mar 20229:00 amRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSOperational Update and Placing
15th Mar 20229:00 amRNSPrice Monitoring Extension
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:35 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 202211:05 amRNSSecond Price Monitoring Extn
14th Mar 202211:00 amRNSPrice Monitoring Extension
14th Mar 20229:05 amRNSSecond Price Monitoring Extn
14th Mar 20229:00 amRNSPrice Monitoring Extension
8th Mar 20228:34 amRNSNovum Securities Limited Company Update Note
8th Mar 20227:00 amRNSCorporate Update
21st Feb 20229:06 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
16th Feb 202211:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.